| Dr Vanessa Rose Green, DO | |
|
189 Storrs Rd, Mansfield Center, CT 06250-1683 | |
| (860) 456-1311 | |
| Not Available |
| Full Name | Dr Vanessa Rose Green |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 189 Storrs Rd, Mansfield Center, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093036378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0102203122 (Virginia) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 72770 (Connecticut) | Primary |
| Entity Name | Natchaug Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295811321 PECOS PAC ID: 5395648737 Enrollment ID: O20040202000008 |
News Archive
A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.
The biotech company Omnio based in Swedish Umeå, and led by researcher Tor Ny at Umeå University, launches a research collaboration with the Canadian pharmaceutical company ProMetic to develop a new drug for slow-healing chronic wounds. The collaboration includes funding for clinical studies of a drug based on the blood plasma protein plasminogen.
A new study led by researchers from the UCLA School of Nursing has found that nursing intervention can significantly decrease substance abuse among homeless youth.
Research presented at the 2007 Annual Meeting of the American Association for Cancer Research confirmed that there is now an effective treatment option for colorectal cancer patients for whom all other treatment options have been exhausted, cetuximab.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vanessa Rose Green, DO 189 Storrs Rd, Mansfield Center, CT 06250-1683 Ph: () - | Dr Vanessa Rose Green, DO 189 Storrs Rd, Mansfield Center, CT 06250-1683 Ph: (860) 456-1311 |
News Archive
A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.
The biotech company Omnio based in Swedish Umeå, and led by researcher Tor Ny at Umeå University, launches a research collaboration with the Canadian pharmaceutical company ProMetic to develop a new drug for slow-healing chronic wounds. The collaboration includes funding for clinical studies of a drug based on the blood plasma protein plasminogen.
A new study led by researchers from the UCLA School of Nursing has found that nursing intervention can significantly decrease substance abuse among homeless youth.
Research presented at the 2007 Annual Meeting of the American Association for Cancer Research confirmed that there is now an effective treatment option for colorectal cancer patients for whom all other treatment options have been exhausted, cetuximab.
› Verified 2 days ago
Dr. Craig Martin, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 189 Storrs Rd, Mansfield Center, CT 06250 Phone: 860-456-1311 Fax: 860-450-0165 | |
Deborah A Weidner, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 189 Storrs Rd, Natchaug Hospital, Mansfield Center, CT 06250 Phone: 860-456-1311 | |
Paul E. Weigle, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 189 Storrs Rd, Mansfield Center, CT 06250 Phone: 860-456-1311 Fax: 860-423-5922 | |
Gengyun Wen, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 189 Storrs Rd, Natchaug Hospital, Mansfield Center, CT 06250 Phone: 860-456-1311 | |
Dr. Sarah Jane De Asis Vargas, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 140 N Frontage Rd, Mansfield Center, CT 06250 Phone: 860-774-2020 | |
Dr. Stanley Paul Dugan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9 Overlook Dr, Mansfield Center, CT 06250 Phone: 860-456-0257 |